This study therefore quantifies angiogenesis and the number of proliferating ECs in addition to the expression of HIF-1α, VEGF and TF in hyperplastic lesions, in situ and invasive breast carcinomas, to determine whether angiogenesis may have a role in dysplastic transformation. This evidence concerns the gene VEGFA and invasive breast carcinoma.